Updates are available Correction dated 2024-08-07
Click to view Correction: https://doi.org/10.1186/s12920-024-01968-7
-
Authors
Bozkurt-Yozgatli, Tugce
Pehlivan, Davut
Gibbs, Richard A.
Sezerman, Ugur
Posey, Jennifer E.
Lupski, James R.
Coban-Akdemir, Zeynep
- License Information
-
More Information
Article History
Received: 4 January 2024
Accepted: 27 March 2024
First Online: 16 April 2024
Change Date: 7 August 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12920-024-01968-7
Declarations
:
: The study was approved by an institutional review board (IRB approval number: H-29697) at Baylor College of Medicine.
: All participants in the study gave written informed consent for participation and publication of clinical information.
: J.R.L. has stock ownership in 23andMe and is a paid consultant for Genomics International. The Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from molecular genetic and genomic testing offered at Baylor Genetics (BG) (). J.R.L. serves on the Scientific Advisory Board of BG. D.P. provides consulting service for Ionis Pharmaceuticals. The other authors declare no competing financial interests.
